Investing
US FDA approves Regeneron’s 8-mg dose of eye disease drug Eylea
© Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo
(Reuters) – The U.S. Food and Drug Administration approved the 8-mg dose of Regeneron (NASDAQ:) Pharmaceuticals’ eye disease drug Eylea, the company said in a statement on Friday.
Read the full article here
-
Investing5 days ago
Hurricane Helene Hits Spruce Pine Mine, Quartz Used for Tech
-
Side Hustles6 days ago
5 Key Strategies for a Seamless Cloud Migration
-
Investing6 days ago
Israel stocks lower at close of trade; TA 35 down 0.23% By Investing.com
-
Side Hustles6 days ago
Why the Future of Cybersecurity Marketing Relies on Trust
-
Side Hustles5 days ago
VP Exec’s Top Tips for Negotiating and Relationship-Building
-
Passive Income6 days ago
Go Paperless with the PDF Reader Pro for $49.99
-
Side Hustles5 days ago
Why the Smallest Details Mean the Most in Marketing
-
Make Money4 days ago
The Top Employers and Opportunities for Part-Time Remote Jobs